Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Nason

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus StrainsAndrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
The New England Journal of Medicine|December 2, 2020
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them, Philip R Krause, Thomas R Fleming, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
The New England Journal of Medicine|October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in LiberiaStephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2Kyle Rosenke, Michael A Jarvis, Friederike Feldmann, et al.
Transplantation and Cellular Therapy|May 9, 2021
Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 DeficiencyMark Parta, Kristen Cole, Daniele Avila, et al.
Plos One|September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.
Science (New York, N.Y.)|July 10, 2010
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1Xueling Wu, Zhi-Yong Yang, Yuxing Li, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Annals of Internal Medicine|October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine TrialsDevan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus StrainsAndrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
The New England Journal of Medicine|December 2, 2020
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them, Philip R Krause, Thomas R Fleming, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
The New England Journal of Medicine|October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in LiberiaStephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2Kyle Rosenke, Michael A Jarvis, Friederike Feldmann, et al.
Transplantation and Cellular Therapy|May 9, 2021
Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 DeficiencyMark Parta, Kristen Cole, Daniele Avila, et al.
Plos One|September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.
Science (New York, N.Y.)|July 10, 2010
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1Xueling Wu, Zhi-Yong Yang, Yuxing Li, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Annals of Internal Medicine|October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine TrialsDevan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
Pageof 8